THE IDENTIFICATION OF NEW ANTIBIOTICS, GLCOEPTIDICI. A FIRST STEP TOWARDS SOLVING THE INFECTIOUS COMPLICATIONS OF CLINICAL POLICIES (Q2043397): Difference between revisions

From EU Knowledge Graph
Jump to navigation Jump to search
(‎Changed label, description and/or aliases in 2 languages: Changing unique label-description pair)
(‎Removed claim: financed by (P890): Directorate-General for Regional and Urban Policy (Q8361), Removing unnecessary financed by statement)
Property / financed by
 
Property / financed by: Directorate-General for Regional and Urban Policy / rank
Normal rank
 

Revision as of 09:58, 2 November 2020

Project Q2043397 in Italy
Language Label Description Also known as
English
THE IDENTIFICATION OF NEW ANTIBIOTICS, GLCOEPTIDICI. A FIRST STEP TOWARDS SOLVING THE INFECTIOUS COMPLICATIONS OF CLINICAL POLICIES
Project Q2043397 in Italy

    Statements

    0 references
    12,500.0 Euro
    0 references
    25,000.0 Euro
    0 references
    50.0 percent
    0 references
    28 July 2017
    0 references
    29 August 2018
    0 references
    29 June 2018
    0 references
    ACTYGEA SRL
    0 references
    Q285765 (Deleted Item)
    0 references

    45°38'22.27"N, 8°59'53.59"E
    0 references
    IL SETTORE DELLA SCOPERTA DI NUOVI ANTIBIOTICI, HA PERSO NEL MONDO MOLTO DEL SUO APPEAL, A CAUSA DEGLI ENORMI INVESTIMENTI NECESSARI A PORTARE SUL MERCATO NUOVE ENTIT CHIMICHE. NONOSTANTE QUESTO, LACQUISIZIONE DI RESISTENZE INCROCIATE AGLI ANTIBIOTICI NEI MICRORGANISMI PATOGENI, PORTA ALLA NECESSIT DI INDIVIDUARE NUOVI ANTIBIOTICI IN GRADO DI CONTRASTARE LINSORGENZA DI COMPLICAZIONI INFETTIVE. NEI PAESI SVILUPPATI, LE PATOLOGIE INFETTIVE GRAVI CAUSATE DA MICRORGANISMI MULTIRESISTENTI, COLPI (Italian)
    0 references
    THE AREA OF THE DISCOVERY OF NEW ANTIBIOTICS LOST IN THE VERY WORLD OF ITS APPEAL, DUE TO THE HUGE INVESTMENTS NEEDED TO BRING NEW CHEMICALS TO THE MARKET. DESPITE THIS, LACQUISITION OF THE CROSS-RESISTANCE OF ANTIBIOTICS IN PATHOGENIC MICROORGANISMS, LEADS TO THE NEED TO IDENTIFY NEW ANTIBIOTICS THAT CAN COUNTERACT THE INFECTIOUS COMPLICATIONS OF INFECTIOUS COMPLICATIONS. IN DEVELOPED COUNTRIES, SERIOUS INFECTIOUS DISEASES CAUSED BY MULTI-DRUG RESISTANT MICROORGANISMS (English)
    0 references

    Identifiers

    E89J17001260007
    0 references